FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:126-128 January 10, 2002 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Noda, K. Related Article by Schiller, J. H. PubMed Citation

In 2001 lung cancer caused more than 1 million deaths worldwide. Despite the well-recognized link between tobacco use and the development of lung cancer, the number of new cases continues to rise, especially among women. In girls and women 15 to 64 years of age, lung cancer is now the leading cause of death from cancer, and this disease remains the most common cause of death from cancer in men.¹

During the past 20 years, numerous efforts have been made to reduce the death rate among patients with lung cancer. Treatment involves surgery, radiation therapy, combination chemotherapy, or a combined . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Coleman, A. M., Rendon, B. E., Zhao, M., Qian, M.-W., Bucala, R., Xin, D., Mitchell, R. A. (2008). Cooperative Regulation of Non-Small Cell Lung Carcinoma Angiogenic Potential by Macrophage Migration Inhibitory Factor and Its Homolog, D-Dopachrome Tautomerase. J. Immunol. 181: 2330-2337 [Abstract] [Full Text]  
• Shintani, Y., Maeda, M., Chaika, N., Johnson, K. R., Wheelock, M. J. (2008). Collagen I Promotes Epithelial-to-Mesenchymal Transition in Lung Cancer Cells via Transforming Growth Factor Signaling. Am. J. Respir. Cell Mol. Bio. 38: 95-104 [Abstract] [Full Text]  
• Hittelman, W. N., Liu, D. D., Kurie, J. M., Lotan, R., Lee, J. S., Khuri, F., Ibarguen, H., Morice, R. C., Walsh, G., Roth, J. A., Minna, J., Ro, J. Y., Broxson, A., Hong, W. K., Lee, J. J. (2007). Proliferative Changes in the Bronchial Epithelium of Former Smokers Treated With Retinoids. JNCI J Natl Cancer Inst 99: 1603-1612 [Abstract] [Full Text]  
• Zagorski, W. A., Knudsen, E. S., Reed, M. F. (2007). Retinoblastoma Deficiency Increases Chemosensitivity in Lung Cancer. Cancer Res. 67: 8264-8273 [Abstract] [Full Text]  
• Lopez-Lazaro, M. (2006). Hypoxia-Inducible Factor 1 as a Possible Target for Cancer Chemoprevention. Cancer Epidemiol. Biomarkers Prev. 15: 2332-2335 [Abstract] [Full Text]  
• Perry, M. C. (2006). Reponses to Topoisomerase-I Inhibitors in Extensive Small-Cell Lung Cancer: Chance or Chromosomes?. JCO 24: 1980-1981 [Full Text]  
• Murakami, H., Yokoyama, A., Kondo, K., Nakanishi, S., Kohno, N., Miyake, M. (2005). Circulating Aminopeptidase N/CD13 Is an Independent Prognostic Factor in Patients with Non-Small Cell Lung Cancer. Clin. Cancer Res. 11: 8674-8679 [Abstract] [Full Text]  
• Nguyen, C. L., Scott, W. J., Young, N. A., Rader, T., Giles, L. R., Goldberg, M. (2005). Radiofrequency Ablation of Primary Lung Cancer: Results From an Ablate and Resect Pilot Study. Chest 128: 3507-3511 [Abstract] [Full Text]  
• Rodriguez, P. C., Hernandez, C. P., Quiceno, D., Dubinett, S. M., Zabaleta, J., Ochoa, J. B., Gilbert, J., Ochoa, A. C. (2005). Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J. Exp. Med. 202: 931-939 [Abstract] [Full Text]  
• Onn, A., Choe, D. H., Herbst, R. S., Correa, A. M., Munden, R. F., Truong, M. T., Vaporciyan, A. A., Isobe, T., Gilcrease, M. Z., Marom, E. M. (2005). Tumor Cavitation in Stage I Non-Small Cell Lung Cancer: Epidermal Growth Factor Receptor Expression and Prediction of Poor Outcome. Radiology 237: 342-347 [Abstract] [Full Text]  
• Qadri, S. S.A., Wang, J.-H., Coffey, J.C., Alam, M., O'Donnell, A., Aherne, T., Redmond, H. P. (2005). Can Surgery for Cancer Accelerate the Progression of Secondary Tumors Within Residual Minimal Disease at Both Local and Systemic Levels?. Ann. Thorac. Surg. 80: 1046-1051 [Abstract] [Full Text]  
• Mulshine, J. L. (2005). Clinical Issues in the Management of Early Lung Cancer. Clin. Cancer Res. 11: 4993s-4998s [Abstract] [Full Text]  
• Qadri, S. S.A., Wang, J.-H., Coffey, J. C., Alam, M., O'Donnell, A., Aherne, T., Redmond, H. P. (2005). Surgically Induced Accelerated Local and Distant Tumor Growth is Significantly Attenuated by Selective COX-2 Inhibition. Ann. Thorac. Surg. 79: 990-995 [Abstract] [Full Text]  
• Fukumoto, S.-i., Yamauchi, N., Moriguchi, H., Hippo, Y., Watanabe, A., Shibahara, J., Taniguchi, H., Ishikawa, S., Ito, H., Yamamoto, S., Iwanari, H., Hironaka, M., Ishikawa, Y., Niki, T., Sohara, Y., Kodama, T., Nishimura, M., Fukayama, M., Dosaka-Akita, H., Aburatani, H. (2005). Overexpression of the Aldo-Keto Reductase Family Protein AKR1B10 Is Highly Correlated with Smokers' Non-Small Cell Lung Carcinomas. Clin. Cancer Res. 11: 1776-1785 [Abstract] [Full Text]  
• Denlinger, C. E., Rundall, B. K., Jones, D. R. (2004). Proteasome inhibition sensitizes non-small cell lung cancer to histone deacetylase inhibitor-induced apoptosis through the generation of reactive oxygen species. J. Thorac. Cardiovasc. Surg. 128: 740-748 [Abstract] [Full Text]  
• Denlinger, C. E., Rundall, B. K., Keller, M. D., Jones, D. R. (2004). Proteasome Inhibition Sensitizes Non-Small-Cell Lung Cancer to Gemcitabine-Induced Apoptosis. Ann. Thorac. Surg. 78: 1207-1214 [Abstract] [Full Text]  
• Silvestri, G (2004). Chemotherapy for advanced lung cancer: is the glass half full or half empty?. Thorax 59: 821-821 [Full Text]  
• Jin, H., Yang, R., Fong, S., Totpal, K., Lawrence, D., Zheng, Z., Ross, J., Koeppen, H., Schwall, R., Ashkenazi, A. (2004). Apo2 Ligand/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Cooperates with Chemotherapy to Inhibit Orthotopic Lung Tumor Growth and Improve Survival. Cancer Res. 64: 4900-4905 [Abstract] [Full Text]  
• Nuciforo, P, Fraggetta, F (2004). Cancer stem cell theory: pathologists' considerations and ruminations about wasting time and wrong evaluations. J. Clin. Pathol. 57: 782-782 [Full Text]  
• Denlinger, C. E., Keller, M. D., Mayo, M. W., Broad, R. M., Jones, D. R. (2004). Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 127: 1078-1086 [Abstract] [Full Text]  
• Dosaka-Akita, H., Miyoshi, E., Suzuki, O., Itoh, T., Katoh, H., Taniguchi, N. (2004). Expression of N-Acetylglucosaminyltransferase V Is Associated with Prognosis and Histology in Non-Small Cell Lung Cancers. Clin. Cancer Res. 10: 1773-1779 [Abstract] [Full Text]  
• Spira, A., Ettinger, D. S. (2004). Multidisciplinary Management of Lung Cancer. NEJM 350: 379-392 [Full Text]  
• Santoro, A., Cavina, R., Latteri, F., Zucali, P. A., Ginanni, V., Campagnoli, E., Ferrari, B., Morenghi, E., Pedicini, V., Roncalli, M., Alloisio, M., Ravasi, G., Soto Parra, H. J. (2004). Activity of a specific inhibitor, gefitinib (IressaTM, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer. Ann Oncol 15: 33-37 [Abstract] [Full Text]  
• Onn, A., Correa, A. M., Gilcrease, M., Isobe, T., Massarelli, E., Bucana, C. D., O'Reilly, M. S., Hong, W. K., Fidler, I. J., Putnam, J. B., Herbst, R. S. (2004). Synchronous Overexpression of Epidermal Growth Factor Receptor and HER2-neu Protein Is a Predictor of Poor Outcome in Patients with Stage I Non-Small Cell Lung Cancer. Clin. Cancer Res. 10: 136-143 [Abstract] [Full Text]  
• Ferrone, M., Motl, S. E (2003). Trastuzumab for the Treatment of Non-Small-Cell Lung Cancer. The Annals of Pharmacotherapy 37: 1904-1908 [Abstract] [Full Text]  
• Onn, A., Isobe, T., Itasaka, S., Wu, W., O'Reilly, M. S., Ki Hong, W., Fidler, I. J., Herbst, R. S. (2003). Development of an Orthotopic Model to Study the Biology and Therapy of Primary Human Lung Cancer in Nude Mice. Clin. Cancer Res. 9: 5532-5539 [Abstract] [Full Text]  
• Castelao, J. E., Bart, R. D. III, DiPerna, C. A., Sievers, E. M., Bremner, R. M. (2003). Lung cancer and cyclooxygenase-2. Ann. Thorac. Surg. 76: 1327-1335 [Abstract] [Full Text]  
• Roberts, T. G. Jr, Lynch, T. J. Jr, Chabner, B. A. (2003). The Phase III Trial in the Era of Targeted Therapy: Unraveling the "Go or No Go" Decision. JCO 21: 3683-3695 [Abstract] [Full Text]  
• Herbst, R. S., Hammond, L. A., Carbone, D. P., Tran, H. T., Holroyd, K. J., Desai, A., Williams, J. I., Bekele, B. N., Hait, H., Allgood, V., Solomon, S., Schiller, J. H. (2003). A Phase I/IIA Trial of Continuous Five-Day Infusion of Squalamine Lactate (MSI-1256F) Plus Carboplatin and Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer. Clin. Cancer Res. 9: 4108-4115 [Abstract] [Full Text]  
• Fossella, F., Pereira, J. R., von Pawel, J., Pluzanska, A., Gorbounova, V., Kaukel, E., Mattson, K. V., Ramlau, R., Szczesna, A., Fidias, P., Millward, M., Belani, C. P. (2003). Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non-Small-Cell Lung Cancer: The TAX 326 Study Group. JCO 21: 3016-3024 [Abstract] [Full Text]  
• Zheng, Y.-L., Loffredo, C. A., Yu, Z., Jones, R. T., Krasna, M. J., Alberg, A. J., Yung, R., Perlmutter, D., Enewold, L., Harris, C. C., Shields, P. G. (2003). Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls. Carcinogenesis 24: 269-274 [Abstract] [Full Text]  
• Alberts, W. M. (2003). Lung Cancer Guidelines: Introduction. Chest 123: 1S-2S [Full Text]  
• Kisley, L. R., Barrett, B. S., Bauer, A. K., Dwyer-Nield, L. D., Barthel, B., Meyer, A. M., Thompson, D. C., Malkinson, A. M. (2002). Genetic Ablation of Inducible Nitric Oxide Synthase Decreases Mouse Lung Tumorigenesis. Cancer Res. 62: 6850-6856 [Abstract] [Full Text]  
• Mulshine, J L, Smith, R A (2002). Lung cancer * 2: Screening and early diagnosis of lung cancer. Thorax 57: 1071-1078 [Abstract] [Full Text]  
• Kisley, L. R., Barrett, B. S., Dwyer-Nield, L. D., Bauer, A. K., Thompson, D. C., Malkinson, A. M. (2002). Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice. Carcinogenesis 23: 1653-1660 [Abstract] [Full Text]  
• (2002). Chemotherapy for Lung Cancer. JWatch General 2002: 1-1 [Full Text]